Sana Biotechnology Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +67.6% | -50.3% | +4.0% | +4.2% | +88.3% | -52.2% | -21.7% | – | – | -21.7% | – | – | |
| – | – | – | – | – | – | -147.8% | – | – | – | – | – | – | |
| – | +310.7% | +35.3% | -65.1% | +44.9% | -29.6% | +16.5% | +2.2% | -17.0% | +47.5% | -51.0% | +127.5% | – | |
| – | +8.3% | -21.7% | +1.1% | -14.5% | +23.0% | -33.5% | -10.0% | -0.5% | +18.5% | -5.9% | -6.0% | – | |
| – | +4,054.9% | +22.2% | -55.4% | +25.1% | -17.6% | -0.5% | +87.6% | -54.2% | +40.6% | -42.0% | +84.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -9,055.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -50.6% | – | – | – | – | – | – | – | – | – | – | |
| – | -9,055.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1,501.7% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.